Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity.
Arican O, Aral M, Sasmaz S, Ciragil P. · 2005
Read Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. by Arican O, Aral M, Sasmaz S, Ciragil P. (2005) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc1533889.txt.
Description
Psoriasis, a scaly skin disease, is driven by an overactive immune reply. Arican and co-authors measured immune signals in blood in 2005, hunting a lab marker of severity. Doctors now grade severity by eye, using a skin score. The team compared patients with active disease to healthy controls.
Six signals, including TNF-alpha and interleukin-18, ran higher in patients than controls. Four of them, IFN-gamma, IL-12, IL-17, and IL-18, rose in step with the skin score. Arican suggests blood levels of these signals could grade disease fairly, without relying on a doctor's visual judgment alone.
Catalog record
| CREATOR | Arican O, Aral M, Sasmaz S, Ciragil P. |
|---|---|
| YEAR | 2005 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 24 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |